Funding Opportunity RFA-MH-20-128 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications to develop standards that describe experimental protocols that are being conducted as part of the BRAIN Initiative. It is expected that applications will solicit community input at all stages of the process. It is recommended that the first step of standard development will involve sharing data between different key groups in the experimental community in order to ensure that the developing standard will cover the way that all of those groups are collecting data. The developed standard is expected to be made widely available.

The UW Advanced Research Computing Center (https://arcc.uwyo.edu/content/home) provides access to world-class computational resources, and the Wyoming INBRE…
From University of Wyoming - Sat, 22 Feb 2020 02:16:02 GMT - View all Laramie, WY jobs

Notice NOT-GM-20-020 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HS-20-002 from the NIH Guide for Grants and Contracts. This initiative will fund the dissemination and implementation of PCOR clinical and organizational findings into primary care practices to improve healthcare quality with a focus on cardiovascular care. AHRQ is particularly interested in applications from States with the highest cardiovascular disease (CVD) burden. The initiative will accomplish this goal by catalyzing the development of a sustainable, State-based external primary care quality improvement (QI) support infrastructure to expand the States current and future capacity to disseminate and implement PCOR evidence into primary care practice.

Notice NOT-GM-20-019 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-012 from the NIH Guide for Grants and Contracts

Competitive Salary: Dana-Farber Cancer Institute: Chronic lymphocytic leukemia (CLL) remains the most common leukemia of adults and is incurable. Several... MA - Massachusetts

Competitive Salary: EMBL: Marine Biocurator/Senior Marine Biocurator Location: Cambridge, Cambridgeshire, England

Notice NOT-DA-20-032 from the NIH Guide for Grants and Contracts

Notice NOT-AT-20-004 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-026 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-030 from the NIH Guide for Grants and Contracts

F. Hoffmann-La Roche AG: Roche Pharma Research and Early Development (pRED) translates extraordinary science into medical innovation through a diversity of technologies and t Switzerland (CH)

F. Hoffmann-La Roche AG: Roche Pharma Research and Early Development (pRED) translates extraordinary science into medical innovation through a diversity of technologies and t Switzerland (CH)

Notice NOT-MD-20-014 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-023 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-037 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-115 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

£28,266 to £32,202: Cefas: s one of the UK's largest, leading and most diverse applied marine science centres, Cefas seeks to recruit a specialist in next generation sequenci... Weymouth

Funding Opportunity RFA-DA-20-028 from the NIH Guide for Grants and Contracts. NIDA is interested in research that addresses research gaps related to the delivery of integrated treatment services for HIV and opioid use disorder (OUD) among the justice-involved population in the US, with a goal of improving treatment management and implementation. A quarter of people with HIV pass through the justice system each year, making it an important system for HIV prevention and treatment. Community re-entry from incarceration is a time of heightened risk for opioid relapse, mortality, HIV risk behaviors, and discontinuation of HIV treatment. Given these elevated levels of risk, justice-involved PWID should be prioritized for screening and linkage to the full continuum of HIV prevention and treatment services, including Pre-exposure prophylaxis (PrEP) and highly active antiretroviral therapy (HAART). There is a need to better understand the effectiveness of the clinical interventions as received in this population, as well as the methods by which those interventions are delivered (navigation/mobile services).